BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19202101)

  • 1. Probiotics prevent enterohaemorrhagic Escherichia coli O157:H7-mediated inhibition of interferon-gamma-induced tyrosine phosphorylation of STAT-1.
    Jandu N; Zeng ZJ; Johnson-Henry KC; Sherman PM
    Microbiology (Reading); 2009 Feb; 155(Pt 2):531-540. PubMed ID: 19202101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enterohemorrhagic Escherichia coli O157:H7 disrupts Stat1-mediated gamma interferon signal transduction in epithelial cells.
    Ceponis PJ; McKay DM; Ching JC; Pereira P; Sherman PM
    Infect Immun; 2003 Mar; 71(3):1396-404. PubMed ID: 12595457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple seropathotypes of verotoxin-producing Escherichia coli (VTEC) disrupt interferon-gamma-induced tyrosine phosphorylation of signal transducer and activator of transcription (Stat)-1.
    Jandu N; Shen S; Wickham ME; Prajapati R; Finlay BB; Karmali MA; Sherman PM
    Microb Pathog; 2007; 42(2-3):62-71. PubMed ID: 17174521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditioned medium from enterohemorrhagic Escherichia coli-infected T84 cells inhibits signal transducer and activator of transcription 1 activation by gamma interferon.
    Jandu N; Ceponis PJ; Kato S; Riff JD; McKay DM; Sherman PM
    Infect Immun; 2006 Mar; 74(3):1809-18. PubMed ID: 16495555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying mechanisms by which Escherichia coli O157:H7 subverts interferon-γ mediated signal transducer and activator of transcription-1 activation.
    Ho NK; Crandall I; Sherman PM
    PLoS One; 2012; 7(1):e30145. PubMed ID: 22253910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface-layer protein extracts from Lactobacillus helveticus inhibit enterohaemorrhagic Escherichia coli O157:H7 adhesion to epithelial cells.
    Johnson-Henry KC; Hagen KE; Gordonpour M; Tompkins TA; Sherman PM
    Cell Microbiol; 2007 Feb; 9(2):356-67. PubMed ID: 16925785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enterohemorrhagic Escherichia coli O157:H7 Shiga toxins inhibit gamma interferon-mediated cellular activation.
    Ho NK; Ossa JC; Silphaduang U; Johnson R; Johnson-Henry KC; Sherman PM
    Infect Immun; 2012 Jul; 80(7):2307-15. PubMed ID: 22526675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.
    Rund SA; Rohde H; Sonnenborn U; Oelschlaeger TA
    Int J Med Microbiol; 2013 Jan; 303(1):1-8. PubMed ID: 23312798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enterohaemorrhagic, but not enteropathogenic, Escherichia coli infection of epithelial cells disrupts signalling responses to tumour necrosis factor-alpha.
    Gareau MG; Ho NK; Brenner D; Sousa AJ; LeBourhis L; Mak TW; Girardin SE; Philpott DJ; Sherman PM
    Microbiology (Reading); 2011 Oct; 157(Pt 10):2963-2973. PubMed ID: 21798984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice.
    Takahashi M; Taguchi H; Yamaguchi H; Osaki T; Komatsu A; Kamiya S
    FEMS Immunol Med Microbiol; 2004 Jul; 41(3):219-26. PubMed ID: 15196571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enterohemorrhagic Escherichia coli O157:H7 gene expression profiling in response to growth in the presence of host epithelia.
    Jandu N; Ho NK; Donato KA; Karmali MA; Mascarenhas M; Duffy SP; Tailor C; Sherman PM
    PLoS One; 2009; 4(3):e4889. PubMed ID: 19293938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strain-specific probiotic (Lactobacillus helveticus) inhibition of Campylobacter jejuni invasion of human intestinal epithelial cells.
    Wine E; Gareau MG; Johnson-Henry K; Sherman PM
    FEMS Microbiol Lett; 2009 Nov; 300(1):146-52. PubMed ID: 19765084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacillus amyloliquefaciens TL106 protects mice against enterohaemorrhagic Escherichia coli O157:H7-induced intestinal disease through improving immune response, intestinal barrier function and gut microbiota.
    Bao CL; Liu SZ; Shang ZD; Liu YJ; Wang J; Zhang WX; Dong B; Cao YH
    J Appl Microbiol; 2021 Jul; 131(1):470-484. PubMed ID: 33289241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function.
    Johnson-Henry KC; Donato KA; Shen-Tu G; Gordanpour M; Sherman PM
    Infect Immun; 2008 Apr; 76(4):1340-8. PubMed ID: 18227169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intimin type influences the site of human intestinal mucosal colonisation by enterohaemorrhagic Escherichia coli O157:H7.
    Fitzhenry RJ; Pickard DJ; Hartland EL; Reece S; Dougan G; Phillips AD; Frankel G
    Gut; 2002 Feb; 50(2):180-5. PubMed ID: 11788556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune signalling responses in intestinal epithelial cells exposed to pathogenic Escherichia coli and lactic acid-producing probiotics.
    Ho NK; Hawley SP; Ossa JC; Mathieu O; Tompkins TA; Johnson-Henry KC; Sherman PM
    Benef Microbes; 2013 Jun; 4(2):195-209. PubMed ID: 23443951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathelicidin- derived PR39 protects enterohemorrhagic Escherichia coli O157:H7 challenged mice by improving epithelial function and balancing the microbiota in the intestine.
    Haiwen Z; Rui H; Bingxi Z; Qingfeng G; Beibei W; Jifeng Z; Xuemei W; Kebang W
    Sci Rep; 2019 Jul; 9(1):9456. PubMed ID: 31263234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of in vitro enterohemorrhagic Escherichia coli infection using phage and probiotics.
    Dini C; Bolla PA; de Urraza PJ
    J Appl Microbiol; 2016 Jul; 121(1):78-88. PubMed ID: 26969848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enterohemorrhagic Escherichia coli O157 outer membrane vesicles induce interleukin 8 production in human intestinal epithelial cells by signaling via Toll-like receptors TLR4 and TLR5 and activation of the nuclear factor NF-κB.
    Bielaszewska M; Marejková M; Bauwens A; Kunsmann-Prokscha L; Mellmann A; Karch H
    Int J Med Microbiol; 2018 Oct; 308(7):882-889. PubMed ID: 29934223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive effects of multiple pch genes on expression of the locus of enterocyte effacement genes and adherence of enterohaemorrhagic Escherichia coli O157 : H7 to HEp-2 cells.
    Iyoda S; Watanabe H
    Microbiology (Reading); 2004 Jul; 150(Pt 7):2357-2571. PubMed ID: 15256577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.